<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02516449</url>
  </required_header>
  <id_info>
    <org_study_id>CER 20858</org_study_id>
    <nct_id>NCT02516449</nct_id>
  </id_info>
  <brief_title>Assessment of Shared Decision Making Aids in Asthma</brief_title>
  <official_title>Utility of Two Patients Decision Aids About Asthma Inhaled Controller Medication Use in Adult Patients With Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chaire en transfert de connaissances, éducation et prévention en santé respiratoire et cardiovasculaire de l'Université Laval</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chaire sur l'adhésion aux traitements de l'Université Laval</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chaire de recherche du Canada en implantation de la prise de décision partagée dans les soins primaires de l'Université Laval</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of shared decision making aids is
      more effective than usual care in improving asthma knowledge, lessening decisional conflict,
      and enhancing adherence to treatments and asthma control in adult patients with mild to
      severe asthma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in asthma knowledge at 2 months, measured by QCALF score</measure>
    <time_frame>Visit 1 (baseline) and visit 2 (2-month follow-up)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in decisional conflict at 2 months, measured by DCS score</measure>
    <time_frame>Visit 1 (baseline) and visit 2 (2-month follow-up)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in adherence to treatment at 2 months, measured by questionnaire</measure>
    <time_frame>Visit 1 (baseline) and visit 2 (2-month follow-up)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in asthma control at 2 months, measured by ACSS score</measure>
    <time_frame>Visit 1 (baseline) and visit 2 (2-month follow-up)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Patient decision aids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants read and fill a patient decision aid before being provided education on asthma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants do not read and fill a patient decision aid before being provided education on asthma.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient decision aid</intervention_name>
    <description>The patient decision aid is a 12-page A3 size color-printed booklet entitled &quot;Should I take asthma inhaled controller medication to optimize asthma control?&quot;</description>
    <arm_group_label>Patient decision aids</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men or women, aged 18 to 65 years;

          2. Current diagnosis of mild to severe asthma; 2.1) Asthma diagnosis will be made upon
             one of the following criteria: 2.1.1) Forced expiratory volume in one second (FEV1)
             increases by at least 12% after the use of a bronchodilator (and a minimum ≥ 200 mL);
             2.1.2) Current asthma symptoms and a positive methacholine challenge test (20% fall in
             FEV1 after inhalation of a provocative dose of methacholine 16 mg/mL); 2.1.3) A
             respirologist's current diagnosis of asthma found in the patient's medical report.
             2.2) Severity of asthma will be assessed according to prescribed pharmacotherapy, as
             suggested by the 2012 Canadian Thoracic Society Guidelines: 2.2.1) Patients with mild
             asthma using SABA as well as low doses (≤250 mcg/day beclomethasone or equivalent) of
             inhaled glucocorticosteroids; 2.2.2) Patients with moderate asthma using SABA as well
             as low to moderate doses (250mcg/day &lt; dose ≤500 mcg/day beclomethasone or equivalent)
             of inhaled glucocorticosteroids, with or without additional therapy (LABA or LTRA);
             2.2.3) Patients with severe asthma using high doses (&gt;500 mcg/day beclomethasone or
             equivalent) of inhaled glucocorticosteroids, and additional pharmacotherapy (LABA,
             LTRA, or Prednisone), and SABA.

        Exclusion Criteria:

          1. Chronic obstructive pulmonary disease (COPD);

          2. Education on asthma in the last 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis-Philippe Boulet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2015</study_first_posted>
  <last_update_submitted>August 3, 2015</last_update_submitted>
  <last_update_submitted_qc>August 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</investigator_affiliation>
    <investigator_full_name>Louis-Philippe Boulet</investigator_full_name>
    <investigator_title>MD FRCPC FCCP</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

